Developing a computerized cognitive assessment tool to detect Preclinical Alzheimer’s Disease
Apr 20, 2024
This April, we joined the N-CODE study group hosted in Telford, UK. NCODE brings together clinicians and researchers in neurotechnology to co-create solutions for unmet needs that require the development of innovative neurotechnologies to shift the emphasis of diagnosis and management of various neurological conditions from the hospital into the community.
![Ore giving a live demo at NCODE](/images/blog/ncode/ncode_presentation.jpeg)
Our group is developing a computerized cognitive assessment tool to detect Preclinical Alzheimer’s Disease. What was most exciting for me is how easily we could port parts of NeuroFusion's open source code to host a prototype of the experience. Looking forward to deploying it and improving patient outcomes! 🧠
Here's a summary of our report from the event - Using technology to improve the diagnostic accuracy of cognitive assessments for preclinical Alzheimer’s disease
![Ore and NCODE collaborators](/images/blog/ncode/ncode_team.jpeg)
A big thank you to my brilliant collaborators Donnchadh Murphy, Abdel-Karim Al-Tamimi, Melanie Jouaiti, Clarissa Stickland, Dr Miriam Silver and Haeun Sun!
By Ore Ogundipe
You Might Also Like
![User Story: How Fusion Reshaped my Health Journey](/images/blog/user-story-health.webp)
User Story: How Fusion Reshaped my Health Journey
Aug 29, 2023
Understanding the relationship between my diet & well-being
![NeuroFusion at Technology in Psychiatry Summit, 2023](/images/blog/tips/ore_tips_2023.jpeg)
NeuroFusion at Technology in Psychiatry Summit, 2023
Dec 01, 2023
How clinicians and researchers can use NeuroFusion tools monitor individual variance in personal wellbeing and trialling interventions